摘要
目的观察疏血通联合依达拉奉治疗急性进展性卒中的临床效果。方法将68例急性进展性脑卒中患者随机分为两组,对照组34例给予常规药物治疗,观察组34例在对照组治疗基础上加用疏血通注射液及依达拉奉注射液静滴,连用14d。结果观察组疗效明显优于对照组;观察组血液流变学各项指标较对照组有明显改善。结论疏血通联合依达拉奉治疗急性进展性卒中能有效控制病情的发展、恶化,疗效显著,使用安全,值得临床推广。
Objective： To observe the effect of edaravone and Shuxuetong Injection for patients with acute stroke in progression. Methods： 68 patients with acute stroke in progression were randomly divided into 2 groups. The control group （n = 34） were treated with routine therapy. The observe group（ n = 34） were treated with edaravone and Shuxuetong Injection based on routine therapy for 14d. Results： The therapeutic effect and hemorheology of observe group significantly better than that in control group. Conclusion： Combining edaravone and Shuxuetong Injection have significant clinical effect on controlling acute stroke in progression. It＇s safe to use and worthwhile being applied on clinic widely.
出处
《中国中医急症》
2009年第1期23-24,26,共3页
Journal of Emergency in Traditional Chinese Medicine
